| LifeScan, Inc. | Platinum Equity | private equity (including portfolio companies) | drug or medical equipment safety violation | 2003 | $30,600,000 |
| Community Health Systems | Community Health Systems | healthcare services | False Claims Act and related | 2000 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $31,000,000 |
| Education Management Corp. | | | False Claims Act and related | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $31,000,000 |
| Oppenheimer & Co. Inc. | Oppenheimer Holdings | financial services | investor protection violation | 2010 | $31,000,000 |
| Organon | Organon & Co. | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $31,000,000 |
| Abbott Laboratories | Abbott Laboratories | pharmaceuticals | False Claims Act and related | 2003 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $32,500,000 |
| ING | Voya Financial | financial services | investor protection violation | 2006 | $33,000,000 |
| Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2017 | $33,000,000 |
| Nine West Group Inc. | Premier Brands Group Holdings | apparel | price-fixing or anti-competitive practices | 2000 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $34,000,000 |
| Publishers Clearing House | | | consumer protection violation | 2001 | $34,000,000 |
| Harris Originals of NY, Inc. et al. | | | consumer protection violation | 2022 | $34,200,000 |
| GE Funding Capital Market Services, Inc. | | | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $34,250,000 |
| Hachette Book Group Inc. | | | price-fixing or anti-competitive practices | 2013 | $34,791,666 |
| Pfizer | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | $35,000,000 |
| Popular Leasing U.S.A., Inc. | | | consumer protection violation | 2006 | $35,000,000 |
| United States Sales Corporation | | | consumer protection violation | 2000 | $35,300,000 |
| Tempoe LLC | | | consumer protection violation | 2023 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $35,649,417 |
| Organon USA Inc | Organon & Co. | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | $36,000,000 |
| Gambro Healthcare Inc. | Baxter International | medical equipment and supplies | False Claims Act and related | 2005 | $37,500,000 |
| Omnicare Inc. | CVS Health | retailing | False Claims Act and related | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $38,100,000 |
| Millennium Health | Millennium Health | healthcare services | False Claims Act and related | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $38,600,000 |
| Hitachi, Ltd. | Hitachi | diversified | price-fixing or anti-competitive practices | 2011 | $38,977,224 |
| Daiichi Sankyo, Inc. | Daiichi Sankyo | pharmaceuticals | False Claims Act and related | 2015 | $39,000,000 |
| Endo Health Solutions | Endo International | pharmaceuticals | False Claims Act and related | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
| Alyon Technologies, Inc. and Telecollect, Inc. | | | consumer protection violation | 2005 | $39,285,000 |
| Anthem Inc. | Elevance Health | healthcare services | privacy violation | 2020 | $39,500,000 |
| Andrx Corporation | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $40,000,000 |
| Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $40,000,000 |
| Equinox International | | | consumer protection violation | 2000 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | $40,000,000 |
| MetLife | MetLife | financial services | insurance violation | 2012 | $40,000,000 |
| SunTrust Mortgage Inc. | Truist Financial | financial services | mortgage abuses | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| Apria Healthcare Group, Inc. and Apria Healthcare LLC | Blackstone | private equity (including portfolio companies) | False Claims Act and related | 2021 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| Vyera Pharmaceuticals LLC | | | consumer protection violation | 2021 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
| Vyera Pharmaceuticals, LLC and Phoenixus AG | | | price-fixing or anti-competitive practices | 2021 | $40,000,000 |
| CareFusion | Becton Dickinson | medical equipment and supplies | off-label or unapproved promotion of medical products | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,100,000 |
| Universal Music Group | Universal Music Group | entertainment | price-fixing or anti-competitive practices | 2003 | $40,600,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | $40,750,000 |
| Caremark | CVS Health | retailing | kickbacks and bribery | 2008 | $41,000,000 |
| State Farm Mutual Insurance Company | State Farm Insurance | financial services | consumer protection violation | 2005 | $41,000,000 |
| Hyundai Motor Company and Kia Motors | Hyundai Motor | motor vehicles | air pollution violation | 2016 | $41,223,320 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | $42,900,000 |
| Elan Corp. | Perrigo | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $43,399,040 |
| EMD Serono, Inc. | Merck KGaA (EMD) | pharmaceuticals | False Claims Act and related | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $44,300,000 |
| PHH Mortgage Corp. | Ocwen Financial | financial services | mortgage abuses | 2018 | $45,000,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
| Blackbaud Inc. | Blackbaud | information technology | privacy violation | 2023 | $49,500,000 |
| Hynix Semiconductor, Inc. | SK Hynix | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $49,971,842 |
| BlockFi Lending LLC | | | investor protection violation | 2022 | $50,000,000 |
| Bridgestone/Firestone, Inc. | Bridgestone | automotive parts | consumer protection violation | 2001 | $51,500,000 |
| Ford Motor Company | Ford Motor | motor vehicles | motor vehicle safety violation | 2002 | $51,500,000 |
| Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | $55,000,000 |
| House of Prince A/S | | | tobacco litigation | 2006 | $55,400,000 |
| Merck & Co. | Merck | pharmaceuticals | consumer protection violation | 2008 | $58,000,000 |
| Wachovia Bank N.A. | Wells Fargo | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $58,750,000 |
| HSBC | HSBC | financial services | mortgage abuses | 2016 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $59,500,000 |
| First Alliance Mortgage Company | | | mortgage abuses | 2002 | $60,000,000 |
| Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
| Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | $60,000,000 |
| Pfizer Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $60,000,000 |
| Wachovia Securities | Wells Fargo | financial services | investor protection violation | 2008 | $60,000,000 |
| C.R. Bard, Inc. | Becton Dickinson | medical equipment and supplies | drug or medical equipment safety violation | 2020 | $60,000,000 |
| Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | $62,000,000 |
| BASF Corporation | BASF | chemicals | price-fixing or anti-competitive practices | 2000 | $62,258,250 |
| Micron Technology, Inc. | Micron Technology | electrical and electronic equipment | price-fixing or anti-competitive practices | 2010 | $66,774,984 |
| Bank of America | Bank of America | financial services | price-fixing or anti-competitive practices | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $67,000,000 |
| UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2018 | $68,000,000 |
| AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2011 | $68,500,000 |
| Walgreens Boots Alliance | Walgreens Boots Alliance | retailing | False Claims Act and related | 2019 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $69,200,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | $70,000,000 |
| Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | $70,000,000 |
| Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | $71,000,000 |
| Fiat Chrysler | Stellantis | motor vehicles | air pollution violation | 2019 | $72,500,000 |
| JPMorgan Chase | JPMorgan Chase | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $75,000,000 |
| Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | $75,000,000 |
| Cancer Fund of America Inc. | | | consumer protection violation | 2016 | $75,800,000 |
| St. Paul Travelers | Travelers | financial services | price-fixing or anti-competitive practices | 2006 | $77,000,000 |
| ACE, Ltd | Chubb Limited | financial services | price-fixing or anti-competitive practices | 2006 | $80,000,000 |
| Bear Stearns & Co. LLC | JPMorgan Chase | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
| Deutsche Bank | Deutsche Bank | financial services | investor protection violation | 2002 | $80,000,000 |
| J.P. Morgan Chase & Co. | JPMorgan Chase | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
| Lehman Brothers Inc. | | | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
| UBS Warburg LLC | UBS | financial services | investor protection violation | 2002 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $80,000,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754 |
| American Honda Motor Co. Inc. and Honda of America Mfg. Inc. | Honda | motor vehicles | consumer protection violation | 2020 | $85,140,000 |
| Nationstar Mortgage dba Mr. Cooper | Mr. Cooper Group | financial services | consumer protection violation | 2020 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $86,300,000 |
| Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2012 | $90,000,000 |
| Penguin Group (USA) Inc. | Bertelsmann | media | price-fixing or anti-competitive practices | 2014 | $90,000,000 |
| Samsung Semiconductor, Inc. and Samsung Electronics Company, Ltd. | Samsung | diversified | price-fixing or anti-competitive practices | 2007 | $90,000,000 |
| UBS AG | UBS | financial services | price-fixing or anti-competitive practices | 2011 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $90,800,000 |
| Schering-Plough Corporation | Merck | pharmaceuticals | off-label or unapproved promotion of medical products | 2006 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $91,602,000 |
| Colfax Capital Corporation and Culver Capital, LLC, also collectively known as Rome Finance | | | consumer protection violation | 2014 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $92,000,000 |
| Western Union Financial Services, Inc. | Western Union | financial services | anti-money-laundering deficiencies | 2010 | $94,000,000 |
| Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000 |
| Consumer Advocacy Center Inc., dba Premier Student Loan Center | | | consumer protection violation | 2022 | $95,000,000 |
| USA Discounters | | | consumer protection violation | 2016 | $95,900,000 |
| Robert Bosch | Robert Bosch | automotive parts | air pollution violation | 2019 | $98,700,000 |
| AmerisourceBergen Corporation | AmerisourceBergen | wholesalers | drug or medical equipment safety violation | 2018 | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $99,875,000 |
| Barclays Bank PLC | Barclays | financial services | price-fixing or anti-competitive practices | 2016 | $100,000,000 |
